Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

NCT ID: NCT06132958

This clinical trial is studying a new treatment called MK-2870, also known as sacituzumab tirumotecan, for women with endometrial cancer who have already received certain types of treatments. These...

Recruiting

Phase: PHASE3 Conditions: Endometrial Cancer

Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study

NCT ID: NCT06958315

The INSPIRE Study is a clinical trial looking at a medication called inclisiran (Leqvio®) for patients with certain heart and blood vessel conditions, specifically atherosclerotic vascular disease ...

Recruiting

Conditions: Heterozygous Familial Hypercholesterolemia, Atherosclerotic Vascular Disease

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT ID: NCT03486873

This clinical trial, called MK-3475-587, is looking into the long-term safety and effectiveness of a treatment called pembrolizumab (also known as MK-3475) for patients with advanced tumors. If you...

Recruiting

Phase: PHASE3 Conditions: Solid Tumors, Hematologic Malignancies

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

NCT ID: NCT06008756

The CORALreef study is a clinical trial that is looking at a new medication called enlicitide decanoate, which is an oral treatment designed to help lower cholesterol and reduce the risk of serious...

Recruiting

Phase: PHASE3 Conditions: Arteriosclerosis, Hypercholesterolaemia

A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN)

NCT ID: NCT06581198

This clinical trial is studying a new treatment called rapcabtagene autoleucel for patients with systemic lupus erythematosus (SLE) who also have a serious kidney condition known as lupus nephritis...

Recruiting

Phase: PHASE2 Conditions: Lupus Nephritis, Lupus Erythematosus, Systemic

Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

NCT ID: NCT07013760

This clinical trial is looking to understand how effective a medication called tezepelumab is in treating patients with severe asthma in Spain. The study will gather information from patients who h...

Not yet recruiting

Conditions: Asthma

Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI)

NCT ID: NCT05996835

This clinical trial is studying a new treatment called TIN816 for patients who are hospitalized with sepsis-associated acute kidney injury (SA-AKI). Sepsis is a serious condition caused by an infec...

Recruiting

Phase: PHASE2 Conditions: Acute Kidney Injury Due to Sepsis

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT05147220

This clinical trial is investigating the effectiveness and safety of a new medication called remibrutinib compared to an existing treatment, teriflunomide, for people with relapsing multiple sclero...

Recruiting

Phase: PHASE3 Conditions: Relapsing Multiple Sclerosis

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

NCT ID: NCT05976243

This clinical trial is studying a medication called remibrutinib to see if it helps adults with a condition known as Chronic Inducible Urticaria (CINDU), which causes sudden skin reactions like hiv...

Recruiting

Phase: PHASE3 Conditions: Chronic Inducible Urticaria

A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

NCT ID: NCT05985915

This clinical trial is investigating the long-term safety and effectiveness of a medication called ianalumab for people with Sjögren's syndrome, a condition that affects the body's ability to produ...

Recruiting

Phase: PHASE3 Conditions: Sjogrens Syndrome

Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.

NCT ID: NCT06042478

This clinical trial is studying a new medication called remibrutinib for adults with chronic spontaneous urticaria (CSU), a condition that causes itchy hives. The trial will compare remibrutinib to...

Recruiting

Phase: PHASE3 Conditions: Chronic Spontaneous Urticaria

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

NCT ID: NCT06655896

This clinical trial is looking at a new treatment called rapcabtagene autoleucel for people with a severe form of scleroderma known as diffuse cutaneous systemic sclerosis. The study aims to see ho...

Recruiting

Phase: PHASE2 Conditions: Scleroderma, Diffuse

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

NCT ID: NCT05888493

This clinical trial is investigating a new treatment called tisagenlecleucel for adults with relapsed or refractory follicular lymphoma, which is a type of cancer that affects the lymphatic system....

Recruiting

Phase: PHASE3 Conditions: Follicular Lymphoma (FL)

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

NCT ID: NCT05562466

This clinical trial is looking at a new treatment called QMF149, which combines two medications, indacaterol and mometasone, to see if it works better than another medication called budesonide for ...

Recruiting

Phase: PHASE3 Conditions: Asthma

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies

NCT ID: NCT05682378

This clinical trial is studying the long-term safety and tolerability of a medication called inclisiran in people who have a condition known as Familial Hypercholesterolemia (HeFH or HoFH). These c...

Recruiting

Phase: PHASE3 Conditions: Heterozygous or Homozygous Familial Hypercholesterolemia

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT ID: NCT05935215

This clinical trial is studying a new treatment called iptacopan for patients with a rare condition known as atypical hemolytic uremic syndrome (aHUS). The goal is to see if switching from their cu...

Recruiting

Phase: PHASE3 Conditions: Atypical Hemolytic Uremic Syndrome

Main Menu

Clinical Trials in Cordoba, Andalucia

16 Active Trials Found in Cordoba

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN)

Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI)

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)